Wang W, Xie X, Yuan T, Wang Y, Zhao F, Zhou Z, Zhang H. Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population-based study. BMC Pregnancy Childbirth. 2021;21(1):364.

Article  PubMed  PubMed Central  Google Scholar 

Cífková R. Hypertension in pregnancy: a diagnostic and therapeutic overview. High Blood Press Cardiovasc Prev. 2023;30(4):289–303.

Article  PubMed  PubMed Central  Google Scholar 

Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, Hall DR, Warren CE, Adoyi G, Ishaku S. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24–43.

Article  CAS  PubMed  Google Scholar 

Borghi C, Ferri C, Sechi L. Clinical management of hypertension in pregnancy. Practical recommendations from the Italian Society of Hypertension (SIIA). [corrected]. High Blood Press Cardiovasc Prev. 2013;20(3):123–7.

Article  PubMed  Google Scholar 

Tomimatsu T, Mimura K, Endo M, Kumasawa K, Kimura T. Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction. Hypertens Res. 2017;40(4):305–10.

Article  CAS  PubMed  Google Scholar 

Chourdakis E, Oikonomou N, Fouzas S, Hahalis G, Karatza AA. Preeclampsia emerging as a risk factor of cardiovascular disease in women. High Blood Press Cardiovasc Prev. 2021;28(2):103–14.

Article  PubMed  Google Scholar 

Tossetta G, Piani F, Borghi C, Marzioni D. Role of CD93 in health and disease. Cells. 2023;12(13):1778.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Piani F, Tossetta G, Cara-Fuentes G, Agnoletti D, Marzioni D, Borghi C. Diagnostic and prognostic role of CD93 in cardiovascular disease: a systematic review. Biomolecules. 2023;13(6):910.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Opichka MA, Rappelt MW, Gutterman DD, Grobe JL, McIntosh JJ. Vascular dysfunction in preeclampsia. Cells. 2021;10(11):3055.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fantone S, Tossetta G, Di Simone N, Tersigni C, Scambia G, Marcheggiani F, Giannubilo SR, Marzioni D. CD93 a potential player in cytotrophoblast and endothelial cell migration. Cell Tissue Res. 2022;387(1):123–30.

Article  CAS  PubMed  Google Scholar 

Strawbridge RJ, Hilding A, Silveira A, Österholm C, Sennblad B, McLeod O, Tsikrika P, Foroogh F, Tremoli E, Baldassarre D, Veglia F, Rauramaa R, Smit AJ, Giral P, Kurl S, Mannarino E, Grossi E, Syvänen AC, Humphries SE, de Faire U, Östenson CG, Maegdefessel L, Hamsten A, Bäcklund A. Soluble CD93 is involved in metabolic dysregulation but does not influence carotid intima-media thickness. Diabetes. 2016;65(10):2888–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Flint EJ, Cerdeira AS, Redman CW, Vatish M. The role of angiogenic factors in the management of preeclampsia. Acta Obstet Gynecol Scand. 2019;98(6):700–7.

Article  PubMed  Google Scholar 

Abplanalp WT, Fischer A, John D, Zeiher AM, Gosgnach W, Darville H, Montgomery R, Pestano L, Allée G, Paty I, Fougerousse F, Dimmeler S. Efficiency and target derepression of anti-miR-92a: results of a first in human study. Nucleic Acid Ther. 2020;30(6):335–45.

Article  CAS  PubMed  Google Scholar 

Hinkel R, Penzkofer D, Zühlke S, Fischer A, Husada W, Xu QF, Baloch E, van Rooij E, Zeiher AM, Kupatt C, Dimmeler S. Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model. Circulation. 2013;128(10):1066–75.

Article  CAS  PubMed  Google Scholar 

Bellera N, Barba I, Rodriguez-Sinovas A, Ferret E, Asín MA, Gonzalez-Alujas MT, Pérez-Rodon J, Esteves M, Fonseca C, Toran N, Garcia Del Blanco B, Pérez A, Garcia-Dorado D. Single intracoronary injection of encapsulated antagomir-92a promotes angiogenesis and prevents adverse infarct remodeling. J Am Heart Assoc. 2014;3(5): e000946.

Article  PubMed  PubMed Central  Google Scholar